Skip to main content
TipRanks
Go Ultimate75% OFF

Emergent Biosolutions (EBS) Q4 2022 Earnings Report

1,363 Followers

EBS Q4 2022 EPS Results

Actual EPS
-$0.31
Consensus EPS
$0.04
Beat/Miss
Missed by -$0.35
One Year Ago EPS
$4.50

EBS Q4 2022 Revenue Results

Actual Revenue
$330.70M
Expected Revenue
$297.18M
Beat/Miss
Beat by +$33.52M
YoY Revenue Growth
-54.27%

Earnings Announcement Details

Quarter
Q4 2022
Date
02/27/2023
Time
After Close
Conference Call
Monday, February 27, 2023
EBS Upcoming Earnings

Emergent Biosolutions's next earnings date is estimated for March 3, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

EBS Q4 2022 Earnings Call
0:00 / 0:00

Q4 2022 Earnings Slide Deck

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

EBS Earnings History

EBS earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 03, 20272026 (Q4)-0.16--0.43――
Nov 02, 20262026 (Q3)-0.39-0.361.06-133.96% (-1.42)
Aug 05, 20262026 (Q2)-0.090.600.16275.00% (+0.44)
Apr 30, 20262026 (Q1)-0.250.210.71-70.42% (-0.50)
Feb 26, 20262025 (Q4)0.11-0.430.05-960.00% (-0.48)
Oct 29, 20252025 (Q3)-0.121.061.37-22.63% (-0.31)
Aug 06, 20252025 (Q2)-0.490.16-2.32106.90% (+2.48)
May 07, 20252025 (Q1)0.440.710.5920.34% (+0.12)
Mar 03, 20252024 (Q4)-0.500.05-0.77106.49% (+0.82)
Nov 06, 20242024 (Q3)0.101.37-0.54353.70% (+1.91)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed